SCHEMBL29339783

SCHEMBL29339783

CCc1nn(Cc2ccc(OC)cc2)cc1Cc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LTA4H P09960 1/20 0.51
▸ CYP19A1 P11511 1/20 0.48
▸ SIGMAR1 Q99720 2/20 0.48
▸ NPC1 O15118 5/20 0.46
▸ RAB9A P51151 5/20 0.46
▸ LMNA P02545 2/20 0.46
▸ MAPT P10636 2/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ CACNA1G O43497 2/20 0.45
▸ CACNA1H O95180 2/20 0.45
▸ CACNA1I Q9P0X4 2/20 0.45
▸ L3MBTL1 Q9Y468 3/20 0.44
▸ KMT2A Q03164 4/20 0.42
▸ MEN1 O00255 3/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29339883 0.85 AADAT (0.40) LTA4HCYP19A1SIGMAR1NPC1RAB9A
SCHEMBL24483861 0.84 LTA4H (0.51) LTA4HCYP19A1SIGMAR1NPC1RAB9A
SCHEMBL3468321 0.81 LTA4H (0.48) LTA4HCYP19A1SIGMAR1NPC1RAB9A
SCHEMBL4552450 0.79 MEN1 (0.45) CYP19A1SIGMAR1NPC1RAB9AMAPT
SCHEMBL27163231 0.79 ALDH1A1 (0.52) LTA4HCYP19A1NPC1RAB9ALMNA
SCHEMBL29339707 0.78 MEN1 (0.44) CYP19A1SIGMAR1NPC1RAB9AMAPT
SCHEMBL29339779 0.77 CYP1A2 (0.46) CYP19A1SIGMAR1NPC1RAB9ALMNA
SCHEMBL29339830 0.77 CACNA1G (0.48) LTA4HCYP19A1SIGMAR1NPC1RAB9A
SCHEMBL370507 0.76 KMT2A (0.53) NPC1RAB9ACACNA1GCACNA1HCACNA1I
SCHEMBL31052484 0.75 AADAT (0.49) CYP19A1NPC1RAB9AMAPTCACNA1G

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239774-A1 SOLUBLE ADENYLYL CYCLASE (SAC) INHIBITORS AND USES THEREOF CORNELL UNIVERSITY (US) 2024-07-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239774-A1 SOLUBLE ADENYLYL CYCLASE (SAC) INHIBITORS AND USES THEREOF UACA, ADCYAP1R1, ADCY1 LTA4H 2152/4885CYP19A1 117/4885SIGMAR1 2801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback